ID   SDT3G
AC   CVCL_D2PS
SY   SDT-3G
DR   Wikidata; Q127384287
RX   PubMed=27251041;
RX   PubMed=28480569;
RX   PubMed=37254642;
RX   PubMed=37365849;
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:124,128, PEZ15:216 and PEZ17:210,214.
CC   Breed/subspecies: English Bulldog; VBO=VBO_0200485.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 225,229
ST   Dog FHC2054: 154,178
ST   Dog FHC2079: 270
ST   Dog PEZ1: 110,114
ST   Dog PEZ6: 188,192
ST   Dog PEZ8: 231
ST   Dog PEZ12: 266
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D2PN ! SDT3
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=27251041; DOI=10.1093/jnen/nlw042; PMCID=PMC4913437;
RA   Dickinson P.J., York D., Higgins R.J., LeCouteur R.A., Joshi N.,
RA   Bannasch D.L.;
RT   "Chromosomal aberrations in canine gliomas define candidate genes and
RT   common pathways in dogs and humans.";
RL   J. Neuropathol. Exp. Neurol. 75:700-710(2016).
//
RX   PubMed=28480569; DOI=10.1111/vco.12317; PMCID=PMC5677578;
RA   York D., Sproul C.D., Chikere N.L., Dickinson P.J., Angelastro J.M.;
RT   "Expression and targeting of transcription factor ATF5 in dog
RT   gliomas.";
RL   Vet. Comp. Oncol. 16:102-107(2018).
//
RX   PubMed=37254642; DOI=10.1111/vco.12912; PMCID=PMC10524959;
RA   Schrock M.S., Zalenski A.A., Tallman M.M., Kollin L., Bratasz A.,
RA   Weeks G., Miller M.A., Sweeney C.N., Pluhar G.E., Olin M.R.,
RA   Kisseberth W.C., Bentley R.T., Dickinson P.J., York D., Webb A., Wang X.,
RA   Moore S., Venere M., Summers M.K.;
RT   "Establishment and characterization of two novel patient-derived lines
RT   from canine high-grade glioma.";
RL   Vet. Comp. Oncol. 21:492-502(2023).
//
RX   PubMed=37365849; DOI=10.1002/vms3.1181; PMCID=PMC10357258;
RA   Fuchs D., Rohrer Bley C., Morandi L., Tonon C., Weyland M.S.,
RA   Nytko-Karouzakis K.J.;
RT   "Triple combination of lomustine, temozolomide and irradiation reduces
RT   canine glioma cell survival in vitro.";
RL   Vet. Med. Sci. 9:1573-1583(2023).
//